These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37003678)

  • 1. Radionuclide Assessment of Sarcoidosis.
    Divakaran S
    Cardiol Clin; 2023 May; 41(2):207-215. PubMed ID: 37003678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.
    Brancato SC; Arrighi JA
    J Nucl Cardiol; 2011 Apr; 18(2):371-4. PubMed ID: 21318450
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in radionuclide imaging of cardiac sarcoidosis.
    Kouranos V; Wells AU; Sharma R; Underwood SR; Wechalekar K
    Br Med Bull; 2015 Sep; 115(1):151-63. PubMed ID: 26311504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of positron emission tomography in the assessment of cardiac sarcoidosis.
    Genovesi D; Bauckneht M; Altini C; Popescu CE; Ferro P; Monaco L; Borra A; Ferrari C; Caobelli F
    Br J Radiol; 2019 Aug; 92(1100):20190247. PubMed ID: 31166768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis.
    Mc Ardle BA; Leung E; Ohira H; Cocker MS; deKemp RA; DaSilva J; Birnie D; Beanlands RS; Nery PB
    J Nucl Cardiol; 2013 Apr; 20(2):297-306. PubMed ID: 23288545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.
    Ishida Y; Yoshinaga K; Miyagawa M; Moroi M; Kondoh C; Kiso K; Kumita S
    Ann Nucl Med; 2014 May; 28(4):393-403. PubMed ID: 24464391
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
    J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-positive (13)N-ammonia/(18)FDG PET for evaluation of cardiac sarcoidosis in a patient on peritoneal dialysis.
    Gonzalez WO; Massera D; Travin MI
    J Nucl Cardiol; 2015 Dec; 22(6):1323-5. PubMed ID: 25762035
    [No Abstract]   [Full Text] [Related]  

  • 9. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis.
    Skali H; Schulman AR; Dorbala S
    Curr Cardiol Rep; 2013 Apr; 15(4):352. PubMed ID: 23544184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of cardiac sarcoidosis: comparison of 18F-FDG PET with 11C-choline PET.
    Miwa S; Inui N; Suda T; Miyazaki H; Torizuka T; Chida K
    Sarcoidosis Vasc Diffuse Lung Dis; 2007 Sep; 24(2):156-8. PubMed ID: 18496990
    [No Abstract]   [Full Text] [Related]  

  • 11. FDG PET imaging in suspected cardiac sarcoidosis: diagnosis vs. prognosis.
    Divakaran S; Blankstein R
    J Nucl Cardiol; 2022 Oct; 29(5):2471-2473. PubMed ID: 34608605
    [No Abstract]   [Full Text] [Related]  

  • 12. Recommendations for
    Kumita S; Yoshinaga K; Miyagawa M; Momose M; Kiso K; Kasai T; Naya M;
    J Nucl Cardiol; 2019 Aug; 26(4):1414-1433. PubMed ID: 31197741
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of follow-up gallium single-photon emission computed tomography and fluorine-18-fluorodeoxyglucose positron emission tomography to predict the deterioration of a patient with cardiac sarcoidosis.
    Kaku B; Kanaya H; Horita Y; Uno Y; Yamazaki T; Fujita T; Ohka T
    Circ J; 2004 Aug; 68(8):802-5. PubMed ID: 15277743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
    Skali H; Schulman AR; Dorbala S
    Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential
    Ostwani W; Hanna C; Brice AE; Wymer DC
    J Nucl Med Technol; 2020 Dec; 48(4):378-380. PubMed ID: 32518122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
    Paz YE; Bokhari S
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.
    Campisi R; Merani MF; Rodríguez MI
    Curr Cardiol Rep; 2022 Dec; 24(12):1873-1882. PubMed ID: 36282434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac FDG/PET imaging mimicking sarcoidosis.
    Lai JKC; Teo E; Lichtenstein M; Toh HB; Sivaratnam D
    J Nucl Cardiol; 2019 Jun; 26(3):1025-1027. PubMed ID: 30627883
    [No Abstract]   [Full Text] [Related]  

  • 19. 18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker.
    Györik S; Ceriani L; Menafoglio A; Gallino A; Wyttenbach R
    Thorax; 2007 Jun; 62(6):560. PubMed ID: 17536038
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by
    Sasson SC; Russo R; Chung T; Chu G; Hunyor I; Williamson J; Murad A; Kane A; Riminton S; Limaye S
    J Med Case Rep; 2017 Oct; 11(1):291. PubMed ID: 29052526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.